Indegene shares rise as Motilal Oswal upgrades stock, sets target at ₹708

Motilal Oswal said Indegene is well-placed to benefit from rising demand for outsourced services and strengthen its strategic role with life sciences clients.

Leave a Reply

Your email address will not be published. Required fields are marked *